D-dimer Prognostic Marker of Cerebral Infarction After Revascularization Procedure

Sex: All

Ages: 18 Years – 65 Years

Healthy volunteers: No

Enrollment: 102

Sponsor: Centre Hospitalier Universitaire, Amiens

Summary

Cerebral infarction is the leading cause of acquired disability in adults. Absence of biological marker used in current practice and identified as a prognostic factor for recovery. D-dimers are degradation products of stabilized fibrin translating an activation of coagulation whatever the cause. Studies have shown that increased D-dimer levels in patients with MI is associated with a higher mortality rate, the link with post-intervention non-revascularization has been demonstrate. The purpose of this project is to search for a correlation between the level of D-dimer and the degree of recovery evaluated by the NIHSS score

Eligibility Criteria

Inclusion Criteria: * Patients aged 18 to 65 * Cerebral infarctions undergoing a revascularization procedure by thrombolysis and / or thrombectomy, at the Amiens University Hospital between January 2015 and December 2020. * Patients having benefited from a D-dimer assay (during their stay) Exclusion Criteria: \-

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT04938479). StuddyBuddy aggregates publicly available trial information.